Lynne Cairns

Title: Lynne Cairns: Innovator in Bacteriophage Research

Introduction

Lynne Cairns is a notable inventor based in Somerville, MA (US). She has made significant contributions to the field of microbiology, particularly in the development of methods to combat bacterial infections. Her innovative approach utilizes bacteriophages to target and eliminate harmful bacteria.

Latest Patents

Lynne Cairns holds a patent for "Methods and compositions for preventing infection by a species." This patent describes compositions and methods designed to prevent, ameliorate, or treat diseases caused by specific bacterial genera, such as cholera. The invention involves the use of two or more strains of lytic bacteriophage that infect and kill bacterial cells. These virulent bacteriophages replicate intracellularly, leading to the lysis and death of the bacteria. By employing multiple strains in a single treatment, the likelihood of bacteria developing simultaneous resistance to all bacteriophage strains is significantly reduced. Importantly, the normal human microbial flora remains unaffected by this treatment. Additionally, the method allows for the co-administration of antibiotic agents or other treatment agents alongside the bacteriophage cocktail.

Career Highlights

Lynne Cairns is affiliated with Tufts University, where she conducts her research and development work. Her innovative contributions to bacteriophage therapy have positioned her as a key figure in the fight against antibiotic-resistant infections.

Collaborations

Lynne has collaborated with esteemed colleagues such as Andrew Camilli and Minmin Yen, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Lynne Cairns is a pioneering inventor whose work in bacteriophage research holds promise for advancing medical treatments against bacterial infections. Her innovative methods and compositions represent a significant step forward in the field of microbiology.